COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 1088: Articles 10871-10880  | Next

Attenuation of antibody titres during 3-6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking as risk factors for lower antibody titres at 6 months
Nomura, Y., Sawahata, M., Nakamura, Y., Koike, R., Katsube, O., Hagiwara, K., Niho, S., Masuda, N., Tanaka, T., Sugiyama, K.
10.1101/2021.11.14.21266334 — Posted: 2021-11-17 Discussion: Onsite
From online data collection to identification of disease mechanisms: The IL-1beta, IL-6 and TNF-alpha; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort
Schultheiss, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Henkes, S.-S., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., Girndt, M., Hoell, J. I., Gekle, M., Mikolajczyk, R., Binder, M.
10.1101/2021.11.16.21266391 — Posted: 2021-11-16
COVID-19 in the Republic of Belarus: pandemic features and the interim safety and efficacy assessment of the Gam-COVID-Vac vaccine
Dashkevich, A. M., Vysotskaya, V. S., Hlinskaya, I. N., Skuranovich, A. L., Tarasenka, A. A., Karaban, I. A., Kolomiets, N. D.
10.1101/2021.11.15.21265526 — Posted: 2021-11-16
COVID-19 in Elderly Patients with Acute Kidney Injury
AYAR, Y., Deniz, O., Doner, B., Kilic, I., Demir, C., Sahin, A.
10.1101/2021.11.16.21266324 — Posted: 2021-11-16
Experience with open schools and preschools in periods of high community transmission of COVID-19 in Norway during the academic year of 2020/2021.
Stebbings, S., Rotevatn, T. A., Larsen, V. B., Suren, P., Elstrom, P., Greve-Isdahl, M., Bjordal Johansen, T., Astrup, E.
10.1101/2021.11.16.21265186 — Posted: 2021-11-16
Assessment of breakthrough infections among post-vaccinated healthcare workers in a Tertiary Dental Hospital in New Delhi, India
Maurya, D., Kaur, A., Faraz, F., Tandon, S., Rana, A., Grover, S.
10.1101/2021.11.15.21266333 — Posted: 2021-11-16
COVID-19 vaccination, risk-compensatory behaviours, and social contacts in four countries in the UK
Buckell, J., Jones, J., Matthews, P. C., Diamond, I., Rourke, E., Studley, R., Cook, D., Walker, A. S., Pouwels, K. B., The COVID-19 Infection Survey Team
10.1101/2021.11.15.21266255 — Posted: 2021-11-16
Continued Effectiveness of COVID-19 Vaccination among Urban Healthcare Workers during Delta Variant Predominance
Lan, F.-Y., Sidossis, A., Iliaki, E., Buley, J., Nathan, N., Bruno-Murtha, L. A., Kales, S. N.
10.1101/2021.11.15.21265753 — Posted: 2021-11-16 Discussion: Onsite
Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., Mukherjee, B.
10.1101/2021.11.15.21266377 — Posted: 2021-11-16
High COVID-19 vaccine coverage allows for a re-opening of European universities
Lasser, J., Hell, T., Garcia, D.
10.1101/2021.11.16.21266383 — Posted: 2021-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).